Glimisave M2 750 Tablet (Glimepiride 2mg / Metformin 750mg)

About Glimisave M 2/750 mg Tablet:

Glimisave M 2/750 mg tablet is a combination of two anti-diabetic medications, used to treat type 2 diabetes mellitus.

Each uncoated bilayered Glimisave M 2/750 mg tablet contains Metformin Hydrochloride 750 mg (as sustained release form) and Glimepiride 2 mg.

Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization.

Glimepiride, an anti-diabetic sulphonylurea, reduces blood glucose by stimulating the insulin release from pancreatic ß-cells and decreases glucose output from the liver. It also increases insulin sensitivity at peripheral target sites.

Use of Glimisave M 2/750 mg Tablet:

Glimisave M 2/750 mg tablet is prescribed for the treatment of Type 2 diabetes mellitus.

Related Product

Usage direction of Glimisave M 2/750 mg Tablet:

• Glimisave M 2/750 mg tablet should be taken orally.

• Glimisave M 2/750 mg tablet should be swallowed whole with help of water.

• Do not crush, chew or break the tablet.

• Do not stop or skip the medicine without physician’s advice.

• Do not consume more than the prescribed quantity.

Preccaution & Related information of Glimisave M 2/750 mg Tablet:

Precaution should be taken & consult with the physician during following conditions:

• Hypersensitivity to this medicine or any of its components.

• Inform your physician if you are going through any other treatment.

• During hypoglycaemia and related problems.

• If find any other complication inform the physician immediately.

• Consult with the physician during pregnancy & lactation.

Storage condition of Glimisave M 2/750 mg Tablet:

• Store between 10°C to 25°C, at dry and dark place.

• Keep all the medicines out of reach of children.